British Journal of Primary Care Nursing (BJPCN)
BJPCN is a digital platform for primary care nurses and healthcare professionals with a specific interest in cardiovascular disease, diabetes and related disorders. The website is a free-access online educational resource, publishing review articles, case studies, back to basics infographics, CPD modules and news. In addition there are special ‘themed’ issues and supplements in print.
Primary Care Cardiovascular Journal (PCCJ)
PCCJ is a digital platform for GPs and healthcare professionals with a specific interest in cardiovascular disease, diabetes and related disorders. The website is a free-access online educational resource, publishing review articles, case studies, back to basics infographics, CPD modules and news. In addition, there are special ‘themed’ issues and supplements in print.
Issues & Answers in Cardiovascular Disease 10-11 November, EMCC Nottingham
Issues & Answers is the UK’s annual conference for primary care GPs and nurses working in the field of cardiovascular disease and associated disorders. With an exciting programme of over 20 sessions from some of the country’s leading experts why not come and join us and help to make best practice, everyday practice. CPD points available.
The following prizes are to be awarded at the UK Stroke Forum Conference 2017
Lifetime Achievement Award
Dr John Bamford has won the 2017 Lifetime Achievement Award, an annual award to recognise those individuals who have made a major contribution to the stroke community. This award is presented by the Chair of the UK Stroke Forum in the first plenary at the UK Stroke Forum conference, below is an insight into John’s achievements.
"John is an inspirational champion of high-quality stroke care who has provided outstanding local and national leadership which has benefitted patients and clinicians. He has recently retired from his consultant post at Leeds General Infirmary but has returned to contribute to the stroke service in Leeds.
"John is a rare individual who has the ‘full package’ - he is an excellent clinician, fantastic teacher, accomplished researcher, and remarkable senior leader. He is a great mentor, for doctors, nurses and allied health professionals, who is always approachable and supportive of colleagues across the UK and internationally. His exemplary commitment to providing high-quality care and service improvement is contagious and remains undiminished despite his retirement.
"John was one of the founders of stroke medicine as a sub-specialty in 1998. He has masterfully guided the development of stroke medicine in the UK throughout his career. He has been both President and Secretary of the British Association of Stroke Physicians and is the inaugural and current Chairman of the Royal College of Physicians Stroke Medicine Committee.
"His judgement, political intuition and negotiating skills have played a major part in the initial and ongoing development of stroke medicine and in the development and delivery of the 2007 English National Stroke Strategy. Without John’s input and guidance stroke medicine and stroke services in the UK would not be where they are today.”
Princess Margaret Memorial Lecture
The Princess Margaret Memorial Lecture sees leading figures in stroke care and research share knowledge and expertise in their field, with the aim of inspiring others to do the same.
This prestigious lecture has been awarded to Professor Martin Dennis who will be sharing insight the challenges of delivering realistic, tailored, evidence-based stroke care at the 12th UK Stroke Forum on Wednesday 29 November at 16:30-17:15.
BASP Warlow Prize - Oral Abstract Presenter
The British Association of Stroke Physicians (BASP) was established in 1999 to promote the advancement of stroke medicine within Great Britain. BASP members are all practising doctors who care for patients who have had a stroke with the aim of providing the highest standard of care.
BASP award the Warlow prize in honour of Professor Charles Warlow, this prize is an impressive all-expenses paid place at the Australian Stroke Society Conference. The winner of this prize is decided at the UK Stroke Conference and presents their winning presentation at the Australian conference in 2018.
British Stroke Research Group - Oral Prize
This prize is for the highest scored overall abstract, in 2017 we had an impressive 313 abstracts submitted from across the whole stroke care pathway.
Professor Hugh Markus has indeed won this prize for the abstracts entitled: ‘The Preserve Trial (Perfusion Substudy): Intensive blood pressure lowering and cerebral blood flow in small vessel disease’. Professor Markus will present his study in the final plenary on Thursday 30 November.
British Stroke Research Group - Poster Prize
This prize is for the poster abstract with the highest score. In 2017 we had an impressive 313 abstracts submitted from across the whole stroke care pathway.
Kate Kelly has indeed won this prize for the abstracts entitled: ‘The Queen Square intensive upper limb rehabilitation program – patient and therapist perceptions’. Kate’s poster will be displayed on Thursday 30 November, with a tour taking place within the Brag and Steal category at 10am.
National Stroke Nursing Forum - Poster Prize
The National Stroke Nursing Forum who works closely with its members to provide local and national networks and opportunities to develop their specialist practice supports the NSNF prize. This prize is to recognise best practice from within the nursing profession and is awarded to the highest scored abstract.
Joanne Prior has indeed won the NSNF Poster Prize for the abstract entitled: ‘Young mums have strokes too...’. Joanne’s poster will be displayed on Wednesday 29 November, with a tour taking place within the Brag and Steal category at 10:45am.
AHP Stroke Abstract Prize
Association of Chartered Physiotherapists in Neurology (ACPIN) is one of the largest Professional Networks recognised by the Chartered Society of Physiotherapy. It is concerned with all aspects of physiotherapy related to the needs of neurologically impaired adults and their relatives and carers. In order to recognise best practice from within the AHP stroke community, ACPIN award an AHP Stroke Abstract Prize to the highest scored abstract from an AHP.
Jacqueline Benfield has indeed won the AHP Stroke Abstract Prize for the abstract entitled: ‘A systematic review and meta-analysis of the effectiveness of biofeedback in dysphagia therapy’. Jacqueline’s presentation will be taking place on Thursday 30 November at 10:45am.
Stroke Rehabilitation SRR Prize
The Society of Research in Rehabilitation (SRR) is the major multidisciplinary rehabilitation research society in the UK. Its aim is to advance education and research into all aspects of the rehabilitation of people with disability and to disseminate the useful results of such research for the public benefit. In order to recognise best practice from within rehabilitation community, SRR award a prize to the highest scored abstract from a rehab coalition member.
Dr Shirley Thomas has won the Stroke Rehabilitation SRR Prize for the abstract entitled: ‘Behavioural activation therapy for depression after stroke (BEADS): a feasibility randomised controlled pilot trial of a psychological intervention for post-stroke depression’. Dr Thomas will present the study in the final plenary on Thursday 30 November.
Patient, Carer Public and Involvement Prize
The PCPI prize aims to encourage and share best practice with teams who have involved stroke survivors or carers in the development of their services or research. This prize is awarded by UK Stroke Forum current and previous Service User Representatives.
Victoria Fleming has won the PCPI prize with the abstract entitled: ‘Listen-In: High-dose home-based auditory comprehension therapy is achievable and effective’. Victoria’s poster will be displayed on Wednesday 29 November, with a tour taking place within the Rehabilitation category at 10:45am.
PCPI Highly Commended
Dr Stefan Tino Kulnik has been highly commended with the abstract entitled: ‘If it works, fine. If it doesn’t, have hope’: A qualitative study to explore individuals’ experiences of managing their severely affected arm after stroke. Dr Kulnik’s poster will be displayed on Wednesday 29 November, with a tour taking place within the Rehabilitation, Assistive Technology, and Translational Research category at 10:45am.
Dr Karolina Gombert has also been highly commended with the abstract entitled: ‘CREATE Collaborative Rehabilitation Environments in Acute STrokE – An Experience-Based Co-Design Approach (EBCD) to improving activity experiences of stroke patients in two hospitals in England’. Dr Gombert’s poster will be displayed on Wednesday 29 November, with a tour taking place within the Brag and Steal category at 10:45am.
We would like to thank the organisations sponsoring the UK Stroke Forum Conference 2017
Bayer - Platinum Level Sponsor
Bayer - Stand D1
For over 120 years, Bayer has been researching and developing innovative medications and new therapeutic approaches that help make a difference to people's lives. Bayer is working in a wide range of therapeutic areas on new treatment approaches for heart, vascular, lung and kidney diseases with a focus on processes and signalling pathways relevant to diseases of the cardiovascular system.
BMS/Pfizer - Gold level sponsor
BMS/Pfizer Alliance – Stand C1
About the Bristol-Myers Squibb/Pfizer Collaboration
In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialise apixaban, an oral anticoagulant discovered by Bristol-Myers Squibb. This global alliance combines Bristol-Myers Squibb's long-standing strengths in cardiovascular drug development and commercialisation with Pfizer’s global scale and expertise in this field.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit http://www.bms.co.uk
Pfizer Ltd.: Working together for a healthier world™
At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines. Our diversified global health care portfolio includes medicines and vaccines, as well as many of the world’s best-known consumer healthcare products. Every day, Pfizer colleagues work to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. In the UK, Pfizer has its business headquarters in Surrey and is a major supplier of medicines to the NHS. To learn more about our commitments, please visit us at www.pfizer.co.uk
Daiichi Sankyo - Gold Level Sponsor
Daiichi Sankyo – Stand D7
Daiichi Sankyo UK Ltd is a Japanese pharmaceutical company that creates and supplies innovative products to help the NHS to deliver better patient care. We specialise in the fields of cardiovascular disease and oncology. We provide medicines and support to the NHS to improve people’s lives every day.
GE Healthcare - Silver level sponsor
GE Healthcare – Stand B10
GE Healthcare are pleased to welcome delegates to this year’s UK Stroke Forum. Come and visit us on the GE Booth B10 for our latest innovations.
GE Healthcare provides transformation medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients.
Firstkind Medical - Bronze level sponsor
Firstkind Medical Ltd. - Stand C4
Firstkind has worked with The University Hospital of North Midlands NHS Trust to introduce geko™ into the stroke pathway when patients are unsuitable for drug prophylaxis and/or contraindicated or intolerant to IPC. Interim analysis highlights that the majority of high risk immobile acute stroke patients who could not tolerate IPC tolerated the geko™ device. These patients would have not been treated as effectively otherwise, with the potential that geko™ will reduce the risk of morbidity and mortality in stroke patients. Please visit stand C4 to find out more.
Novacor - Bronze level sponsor
Novacor – Stand D2
R.Test Evoltion 4 – The obvious choice for AF detection
The R.Test Evolution 4 – Automatic ECG Arrhythmia Detection System is a lightweight non-invasive ECG monitor especially effective for detecting the presence of AF and PAF over longer durations1. Weighing just (42g) and approximately the size of a small matchbox, the R.Test Evolution 4 has become the obvious choice for stroke professionals; providing an effective, swift and practical means to capture and identify or confidently exclude AF as a cause for stroke.
Visit stand no:D2 today for more information.
Omron - Bronze level sponsor
OMRON Healthcare UK Ltd – Stand D5
OMRON Healthcare UK Ltd is committed to improving the quality of everyone’s lives by providing clinically validated, innovative medical equipment for health monitoring, therapy and disease prevention. By looking beyond the technology, our real commitment lies in building healthy lives. We aim to provide a total healthcare management service, aimed at preventing and improving such increasingly common health problems as hypertension, respiratory conditions, diabetes and obesity.
ReNeuron - Bronze level sponsor
General enquiries: firstname.lastname@example.org
ReNeuron is a UK-based global leader in the development of cell-based therapeutics. Its primary objective is the development of novel cell-based therapies targeting areas of significant unmet or poorly met medical need. ReNeuron has used its unique stem cell technologies to develop therapies for significant disease conditions where the cells can be readily administered “off-the-shelf” to any eligible patient.
The lead stem cell candidate, CTX, has been shown to be safe and well-tolerated in a first-in-man (PISCES I) in disabled stroke patients. We have recently announced positive efficacy data from a follow on Phase II clinical trial (PISCES II) of our CTX therapy in disabled stroke patients.
Stryker - Bronze level sponsor
Stryker – Stand E5
Stryker NV is focused on advancing the practice of less invasive stroke therapies through its Complete Stroke Care solutions. Stryker is dedicated to providing innovative stroke products and services for ischemic and hemorrhagic stroke, and committed to providing clinical education and support to help physicians deliver better patient outcomes. Products include: stent retriever, detachable coils, stents, balloons, guidewires and microcatheters.